Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anika Therapeutics

11.00
-0.5300-4.60%
Post-market: 11.000.00000.00%16:24 EDT
Volume:102.76K
Turnover:1.15M
Market Cap:157.76M
PE:-2.83
High:11.58
Open:11.50
Low:10.96
Close:11.53
Loading ...
Jan 24, 2020

Major Issues Report

Current report, items 2.01, 8.01, and 9.01
Jan 07, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Jan 06, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Nov 08, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Nov 01, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Oct 28, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 25, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 30, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 22, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 30, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 30, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 26, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 24, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 10, 2019

Major Issues Report

Current report, item 5.02
Jul 09, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jul 09, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 26, 2019

Major Issues Report

Current report, item 5.02
Jun 21, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Jun 20, 2019

Major Issues Report

Current report, items 5.02, 5.07, and 9.01